Cardiac Troponin Diagnostics—Forecasts and Opportunities to 2025
Demand for High Sensitivity Point-of-Care Testing Enhance Growth Potential
16-Nov-2022
North America
Market Research
PDB7-01-00-00-00
HC03602-NA-MT_27122
Cardiac troponin (cTn) biomarkers are the gold standard in myocardial infarction (MI) diagnosis, leading healthcare professionals to use cTn diagnostics. In addition, a rising number of patients visit emergency departments (EDs) with cardiac complaints, increasing ED demand for kits
that can rapidly rule MI in or out. Both factors serve as significant drivers of the cTn diagnostics market.
Hospitals and clinical laboratories adopt high-sensitivity (hs) assays because of their ability to detect troponin in lower concentrations. The point-of-care testing (POCT) of cTn grows rapidly due to its rising applications in EDs and remote locations. POCT can provide rapid results in a shorter period than lab-based tests. In addition, companies such as QuidelOrtho and Siemens Healthineers have developed high-sensitivity POCT cTn assays that provide accurate results within a few minutes.
In this report, Frost & Sullivan overviews the cTn diagnostics market and includes troponin I and troponin T. Our testing locations are independent laboratories, physicians’ offices, urgent care and nursing facilities, inpatient hospitals, and emergency rooms. The study covers sensitive and
hs-cTn tests.
The report also includes the following:
• Market size by revenue, covering historic and forecast data by segment (lab-based tests and POCT) and region (North America, Europe,
Asia-Pacific, and the rest of the world)
• Challenges and drivers
• Competitive landscape, including company market share for lab-based tests and POCT
• Future trends and growth opportunities for stakeholders
North America is the leading region in the cTn diagnostics market, with hospitals and laboratories shifting toward high-sensitivity assays following approval from the United States Food and Drug Administration in 2017. Frost & Sullivan’s research shows high consolidation in the cTn diagnostics market, with players such as Abbot, Roche, and Siemens Healthineers dominating. New players are entering this market, especially in the POCT segment.
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Cardiac Troponin (cTn) Diagnostics Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Cardiac Biomarkers
Timeline for Cardiac Biomarkers for MI
cTns
Clinical Pathway for MI Diagnosis
cTn Diagnostics
cTn Diagnostics (continued)
Scope of Analysis
Segmentation
Competitors
Growth Metrics
Growth Drivers
Growth Restraints
Forecast Assumptions
Revenue Forecast
Revenue Forecast by Product Type
Revenue Forecast by Region
Revenue Forecast Analysis
Revenue Forecast Analysis (continued)
Revenue Forecast Analysis by Region
Competitive Environment
Revenue Share
Revenue Share Analysis
Company Mapping
Companies to Watch
High-sensitivity Troponin Diagnostic—Emerging Applications
New Biomarkers for MI
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Growth Metrics
Revenue Forecast by Product Type
Revenue Forecast by Region
Forecast Analysis
Growth Opportunity 1: Rapid Diagnostics for EDs
Growth Opportunity 1: Rapid Diagnostics for EDs (continued)
Growth Opportunity 2: hs-cTn POCT
Growth Opportunity 2: hs-cTn POCT (continued)
Growth Opportunity 3: Digital Health and Diagnostics Inter-convergence Model
Growth Opportunity 3: Digital Health and Diagnostics Inter-convergence Model (continued)
Growth Opportunity 4: Specific and Sensitive Assays for Rapid MI Detection
Growth Opportunity 4: Specific and Sensitive Assays for Rapid MI Detection (continued)
Your Next Steps
Why Frost, Why Now?
List of Exhibits
Legal Disclaimer
- cTn Diagnostics: Growth Metrics, Global, 2021
- cTn Diagnostics: Growth Drivers, Global, 2022–2025
- cTn Diagnostics: Growth Restraints, Global, 2022–2025
- cTn Diagnostics: Revenue Forecast, Global, 2017–2025
- cTn Diagnostics: Revenue Forecast by Product Type, Global, 2017–2025
- cTn Diagnostics: Revenue Forecast by Region, 2017–2025
- cTn Diagnostics: Revenue Share of Top Participants, Global, 2021
- cTn Diagnostics: Product Comparison by Company, 2022
- Lab-based Tests: Growth Metrics, Global, 2021
- Lab-based Tests: Revenue Forecast, Global, 2017–2025
- Lab-based Tests: Revenue Forecast by Region, Global, 2017–2025
- POCT: Growth Metrics, Global, 2021
- POCT: Revenue Forecast, Global, 2017–2025
- POCT: Revenue Forecast by Region, Global, 2017–2025
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
17 Nov 2026 | Global | Frost Radar
Frost Radar™: Quantum-Grade Sensor Technology Ecosystem for Healthcare Applications, 2026
Quantum-grade sensors are advancing healthcare by leveraging quantum phenomena to enable highly sensitive, precise, and non-invasive measurements of biological signals and physiological parameters. These innovations enhance diagnostic accuracy, disease monitoring, brain activity measurement, and ear...
16 Nov 2026 | North America | Frost Radar
Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026
This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...
03 Nov 2026 | North America | Market Research
Enterprise Imaging Market, United States, 2025–2030
Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...
02 Nov 2026 | Global | Market Research
Continuous Glucose Monitoring Market, Global, 2026
The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...
28 Oct 2026 | Global | Frost Radar
Frost Radar™: Health Monitoring Wearable Solutions, 2026
The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.